# Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients

Source: https://onco.cc/trials/nct06987734/  
OnCo record `nct06987734` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in lung cancer, run by Shanghai Pulmonary Hospital, Shanghai, China, now recruiting.

## Summary

Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients is a phase 2, interventional study registered as NCT06987734 by Shanghai Pulmonary Hospital, Shanghai, China, with a registry enrolment figure of 25 participants, started 2025-06-19 and due to reach its primary completion in 2027-12-31. Interventions recorded: Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab. Conditions listed: Lung Cancer (NSCLC). Primary outcome: Major Pathological Response. Lung eligibility wording from the registry: "Histologically documented, stage II-IIIA Non-Small Cell Lung Cancer (according to version 9th of the International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology) and previously untreated". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06987734
- Phase: 2
- Setting: Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
- Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
- Enrolled: 25

## Sources

- ClinicalTrials.gov NCT06987734: https://clinicaltrials.gov/study/NCT06987734

## Connected records

- cancers: [Resectable stage I to III non-small-cell lung cancer](https://onco.cc/cancers/resectable-nsclc/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06987734.json